These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 32534139

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.
    Ferro BE, van Ingen J, Wattenberg M, van Soolingen D, Mouton JW.
    J Antimicrob Chemother; 2015 Oct; 70(10):2838-43. PubMed ID: 26142475
    [Abstract] [Full Text] [Related]

  • 23. Lack of activities of amikacin and sulphamethoxazole against Mycobacterium avium-intracellulare.
    Yew WW, Tam CM, Chan CY, Li MS, Cheng AF.
    Int J Clin Pharmacol Res; 1993 Oct; 13(2):65-8. PubMed ID: 8354590
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Antibiotic Susceptibility and Genotyping of Mycobacterium avium Strains That Cause Pulmonary and Disseminated Infection.
    Uchiya KI, Asahi S, Futamura K, Hamaura H, Nakagawa T, Nikai T, Ogawa K.
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378709
    [Abstract] [Full Text] [Related]

  • 26. Genetic research about Mycobacterium avium complex.
    Ogawa K.
    Kekkaku; 2013 Jan; 88(1):17-22. PubMed ID: 23513564
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Relations between clinical subtypes of Mycobacterium avium pulmonary disease and polyclonal infections detected by IS1245 based restriction fragment length polymorphism analysis].
    Kuwabara K, Watanabe Y, Wada K, Tsuchiya T.
    Kekkaku; 2004 Feb; 79(2):39-46. PubMed ID: 15031998
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Genetic diversity of clinical Mycobacterium avium subsp. hominissuis and Mycobacterium intracellulare isolates causing pulmonary diseases recovered from different geographical regions.
    Ichikawa K, van Ingen J, Koh WJ, Wagner D, Salfinger M, Inagaki T, Uchiya KI, Nakagawa T, Ogawa K, Yamada K, Yagi T.
    Infect Genet Evol; 2015 Dec; 36():250-255. PubMed ID: 26435330
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease.
    Maekura R, Miki K, Tateishi Y, Matsumoto S, Kitada S, Miki M, Kida H.
    Microbiol Spectr; 2022 Jun 29; 10(3):e0053022. PubMed ID: 35467367
    [Abstract] [Full Text] [Related]

  • 35. PCR-Based Rapid Identification System Using Bridged Nucleic Acids for Detection of Clarithromycin-Resistant Mycobacterium avium-M. intracellulare Complex Isolates.
    Hirama T, Shiono A, Egashira H, Kishi E, Hagiwara K, Nakamura H, Kanazawa M, Nagata M.
    J Clin Microbiol; 2016 Mar 29; 54(3):699-704. PubMed ID: 26739154
    [Abstract] [Full Text] [Related]

  • 36. The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study.
    Hosono Y, Kitada S, Yano Y, Mori M, Miki K, Miki M, Yoshimura K, Kagawa H, Oshitani Y, Yokota S.
    J Infect Chemother; 2018 May 29; 24(5):353-357. PubMed ID: 29361415
    [Abstract] [Full Text] [Related]

  • 37. Minimum inhibitory concentrations of azithromycin in clinical isolates of Mycobacterium avium complex in Japan.
    Uwamino Y, Aoki W, Inose R, Kamoshita Y, Mikita K, Namkoong H, Nishimura T, Matsushita H, Hasegawa N.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0021824. PubMed ID: 38687080
    [Abstract] [Full Text] [Related]

  • 38. Nationwide analysis of Mycobacterium chimaera and Mycobacterium intracellulare isolates: Frequency, clinical importance, and molecular and phenotypic resistance profiles.
    Truden S, Žolnir-Dovč M, Sodja E, Starčič Erjavec M.
    Infect Genet Evol; 2020 Aug 04; 82():104311. PubMed ID: 32247868
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation.
    Urabe N, Sakamoto S, Tokita N, Yoshida H, Usui Y, Shimizu H, Sekiya M, Miyoshi S, Nakamura Y, Isobe K, Kishi K.
    BMC Pulm Med; 2024 Sep 10; 24(1):442. PubMed ID: 39256717
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.